P688: Sex difference in inflammatory bowel disease patients regarding depression: a nationwide population based study in KoreaECCO'22Year: 2022
Authors: Moon, J.M.(1);Han, K.(2);Shin, S.Y.(1);Choi, C.H.(1);Kim, J.S.(3);
(1)Chung-Ang University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(2)Soongsil University, Department of Statistics and Actuarial Science, Seoul, Korea- Republic Of;(3)Seoul National University College of Medicine, Department of Internal Medicine- Liver Research Institute, Seoul, Korea- Republic Of;
P689: Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in JapanECCO'22Year: 2022
Authors: Miura, M.(1);Shimizu, H.(2);Saito, D.(1);Miyoshi, J.(1);Matsuura, M.(1);Kudo, T.(3);Hirayama, D.(4);Yoshida, M.(5);Arai, K.(2);Iwama, I.(5);Nakase, H.(4);Shimizu, T.(3);Hisamatsu, T.(1);
(1)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan;(2)National Center for Child Health and Development, Division of Gastroenterology, Tokyo, Japan;(3)Juntendo University Faculty of Medicine, Department of Pediatrics, Tokyo, Japan;(4)Sapporo Medical University School of Medicine, Department of Gastroenterology and Hepatology, Sapporo, Japan;(5)Saitama Children’s Medical Center, Division of Gastroenterology and Hepatology, Saitama, Japan;
P690: Rates of IBD in New Zealand Māori population at Lakes District Health Board: low but increasingECCO'22Year: 2022
Authors: Qiu, M.(1);Patel, R.N.(2);Gearry, R.B.(3,4);
(1)University of Auckland, School of Medicine, Auckland, New Zealand;(2)Lakes District Health Board, Gastroenterology, Rotorua, New Zealand;(3)Canterbury District Health Board, Gastroenterology, Christchurch, New Zealand;(4)University of Otago, Department of Medicine, Christchurch, New Zealand;
P691: Influence of ethnicity on the phenotype and clinical outcomes in Inflammatory Bowel Disease; comparison of a South American with a North American population.ECCO'22Year: 2022
Authors: Pérez, T.(1);Pizarro, B.(2); Ascui, G.(3);Tobar, F.(4);Cerda-Villablanca, M.(5);Alvares, D.(6);Orellana, M.(7);De la Vega, A.(8);Canistra, M.(9);Cornejo, B.(9);Baez, P.(10);Silva, V.(2);Arriagada, E.(8);Estela, R.(2);Hernandez-Rocha, C.(11);Alvarez-Lobos, M.(12);Rivera-Nieves, J.(13);
(1)Pontificia Universidad Catolica/Hospital San Borja-Arriaran, Department of Gastroenterology, Región Metropolitana, Chile;(2)Universidad de Chile, Medicina, Santiago, Chile;(3)Universidad de California San Diego, Inmunología, San Diego, United States;(4)Universidad de Chile, Department of Mathematical Engineering, Santiago, Chile;(5)Universidad de Chile, Center for Mathematical Modeling- Universidad de Chile, Santiago, Chile;(6)Pontificia Universidad Católica de Chile, Department of Statistics- Santiago- Chile, Santiago, Chile;(7)Universidad de Chile, Facultad De Ingenieria, Santiago, Chile;(8)Universidad De Chile, Gastroenterologia, Santiago, Chile;(9)Pontificia Universidad Católica de Chile, Medicina, Santiago, Chile;(10)Universidad de Chile, Centro de Informatica Medica y Telemedicina, Santiago, Chile;(11)Pontificia Universidad Católica de Chile, Gastroenterologia, Santiago, Chile;(12)Pontificia Universidad Católica de Chile, Gastroenterología, Santiago, Chile;(13)Universidad de California San Diego, Inflammatory Bowel Disease Center- Division of Gastroenterology- University of California- San Diego- La Jolla- CA- United States., San Diego, United States;Tamara Pérez-Jeldres1a 2 MD Benjamín Pizarro MD3 Felipe Tobar PhD3c Matías Orellana BSc3 Mauricio Cerda-Villablanca PhD3d Danilo Alves PhD1b Andrés de la Vega MD2 Macarena Canistra Bsc1 Bárbara Cornejo BSc1 Pablo Baéz PhD3e Verónica Silva MD2 Elizabeth Arriagada MD2 Ricardo Estela MD2 Gabriel Ascui Bsc4 Cristián Hernández-Rocha MD1a Manuel Álvarez Lobos MD1a Jesús Rivera-Nieves MD. 1 Universidad Católica de Chile Santiago Chile.a Division of Gastroenterology School of Medicine.b Division of Statistic School of Mathematics. 2 Instituto Chileno-Japonés Santiago Chile. 3 Universidad de Chile Santiago Chile. cDivision of Radiology School of Medicine. d Department of Mathematical Engineering. e Center for Mathematical Modeling Universidad de Chile 4 La Jolla Institute for Allergy and Immunology San Diego CA United States. 5 Inflammatory Bowel Disease Center Division of Gastroenterology University of California San Diego La Jolla CA United States.
P692: Clinical, therapeutic and evolutionary profile of fistulizing ano-perineal lesions in Crohn's diseaseECCO'22Year: 2022
Authors: Hassine, H.(1);KAHLAOUI, F.(1);Mtir, M.(1);Cherif, D.(1);Tlili, R.(1);Kchir, H.(1);Maamouri, N.(1);
(1)Rabta Hospital, Gastroenterology, Tunis, Tunisia;
P693: Willingness and hesitancy to the telemedicine in patients with inflammatory bowel disease during COVID-19 outbreak. Preliminary results of a survey in an Italian IBD CenterECCO'22Year: 2022
Authors: Bossa, F.(1);Guerra, M.(1);Carparelli, S.(1);Antonella, M.(1);Terracciano, F.(1);Costantino, A.(2);Caprioli, F.(2);Valvano, M.R.(1);Martino, G.(1);Nardella, M.(1);Perri, F.(1);
(1)Fondazione Casa Sollievo della Sofferenza, Gastroenterology, San Giovanni Rotondo, Italy;(2)Fondazione Ca' Grande Ospedale Maggiore Policlinico di Milano, Gastroenterology and Digestive Endoscopy, Milano, Italy;
P694: COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy.ECCO'22Year: 2022
Authors: Ramos Lopez, L.(1);Carrillo-Palau, M.(1);Alonso-Abreu , I.(1);Reygosa, C.(1);Hernández-Buylla, N.(1);Amaral , C.(1);Hernández, A.(1);Benítez-Zafra, F.(1);Pérez-González, F.(1);Quintana-Díaz, H.(1);Hernández-Guerra, M.(1);
(1)Hospital Universitario De Canarias, Department of Gastroenterology, Santa Cruz De Tenerife, Spain;
P696: Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases – secondary analyses from a randomised clinical trialECCO'22Year: 2022
Authors: Bjørlykke, K.(1,2);Brun, M.K.(2,3);Viken, M.K.(4,5);Stenvik, G.E.(3);Klaasen, R.A.(6);Gehin, J.E.(2,6);Warren, D.J.(6);Sexton, J.(3);Haavardsholm, E.A.(2,3);Jahnsen, J.(1,2);Lie, B.A.(2,4,5);Goll, G.L.(3);Bolstad, N.(6);Syversen, S.W.(3);Jørgensen, K.K.(1);
(1)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Diakonhjemmet Hospital, Division of Rheumatology and Research, Oslo, Norway;(4)Oslo University Hospital, Department of Medical Genetics, Oslo, Norway;(5)Oslo University Hospital, Department of Immunology, Oslo, Norway;(6)Oslo University Hospital, Department of Medical Biochemistry, Oslo, Norway;
P697: Examining the regulatory role of epigenetic and transcriptomic alterations in anti-TNF treatment response and disease progression in patients with Ulcerative ColitisECCO'22Year: 2022
Authors: Lawal, O.(1);Stack, R.(2);Ciara, E.(2);Tosetto, M.(2);McDonnell, C.(1);Rodriguez-Sosa, A.(1);Yochum, G.(3);Koltun, W.(3);Boland, K.(4);Sheahan, K.(5);Doherty, G.(2);Das, S.(1);
(1)Royal College of Surgeons in Ireland, School of Pharmacy and Biomolecular Sciences, Dublin, Ireland;(2)St. Vincents University Hospital, University College Dublin- Center for Colorectal Disease, Dublin, Ireland;(3)Penn State University, College of Medicine, Pennsylvania, United States;(4)Beaumont Hospital, Gastroenterology, Dublin, Ireland;(5)St. Vincents University Hospital, Department of Pathology and Center for Colorectal Disease- University College Dublin, Dublin, Ireland;
P698: Mapping field cancerisation and clonal evolution in IBD colons with dysplasia and colorectal cancerECCO'22Year: 2022
Authors: Yalchin, M.(1);Curtius, K.(2);Nowinski, S.(3);Moorghen, M.(1);Kimberley, C.(3);Smith, K.(3);Baker, A.M.(3);Al-Bakir, I.(3);Mossner, M.(3);Nadhamuni, V.(3);Hart, A.(1);Graham, T.(3);
(1)St. Mark’s Hospital- Inflammatory Bowel Disease Department- Watford Rd- Harrow HA1 3UJ., Inflammatory Bowel Disease Department, London, United Kingdom;(2)Division of Biomedical Informatics- Department of Medicine- University of California San Diego- La Jolla- CA USA, Division of Biomedical Informatics, San Diego, United States;(3)Centre for Genomics and Computational Biology- Barts Cancer Institute- Barts and the London School of Medicine and Dentistry- Queen Mary University of London- Charterhouse Sq- EC1M 6BQ- UK, Centre for Genomics and Computational Biology, London, United Kingdom;
P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT StudyECCO'22Year: 2022
Authors: Chun, J.(1);Suji, K.(2);Kwang Sung, A.(3);Soo Kyung, P.(4);Sangsoo, K.(2);Dong Il, P.(4);
(1)Gangnam Severance Hospital- Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(2)Soongsil University, Bioinformatics, Seoul, Korea- Republic Of;(3)Functional Genome Institute- PDXen Biosystems Inc., Genetics, Seoul, Korea- Republic Of;(4)Kangbuk Samsung Hospital- Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, Korea- Republic Of;
P700: The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relativesECCO'22Year: 2022
Authors: Lee , S.H.(1);Raygoza Garay , J.A.(1);Turpin , W.(1);Smith , M.I.(1);Goethel , A.(1);Griffiths , A.(2);Moayyedi , P.(3);Espin-Garcia , O.(4);Abreu , M.(5);Aumais , G.(6);Bernstein , C.N.(7);Biron , I.(8);Cino , M.(9);Deslandres , C.(10);Dotan , I.(8);El-Matary , W.(11);Feagan , B.(12);Guttman , D.(13);Huynh , H.(14);Hyams , J.(15);Jacobson , K.(16);Mack , D.(17);Marshall , J.(3);Otley , A.(18);Panaccione , R.(19);Ropeleski , M.(20);Silverberg , M.S.(1);Steinhart , A.H.(1);Turner , D.(21);Yerushalmi , B.(22);Xu , W.(4);Croitoru , K.(1);
(1)Mount Sinai Hospital- University of Toronto, Division of Gastroenterology, Toronto, Canada;(2)The Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada;(3)McMaster University- Farncombe Family Digestive Health Research Institute, Department of Medicine, Hamilton, Canada;(4)Dalla Lana School of Public Health- University of Toronto, Division of Biostatistics, Toronto, Canada;(5)Department of Medicine- University of Miami- Miller School of Medicine, Division of Gastroenterology, Miami, United States;(6)Hopital Maisonneuve-Rosemont, Department of Gastroenterology, Montreal, Canada;(7)University of Manitoba, Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, Canada;(8)Rabin Medical Center, Division of Gastroenterology, Petah-Tikva, Israel;(9)University of Toronto, Division of Gastroenterology and Hepatology, Toronto, Canada;(10)CHU Sainte-Justine, Department of Gastroenterology, Montreal, Canada;(11)University of Manitoba, Pediatric Gastroenterology, Winnipeg, Canada;(12)University of Western Ontario, Departments of Medicine- Epidemiology- and Biostatistics, London, Canada;(13)University of Toronto, Centre for the Analysis of Genome Evolution and Function, Toronto, Canada;(14)University of Alberta, Department of Pediatrics, Edmonton, Canada;(15)Connecticut Children’s Medical Center, Division of Digestive Diseases- Hepatology- and Nutrition, Hartford, United States;(16)British Columbia Children's Hospital, Department of Pediatrics, Vancouver, Canada;(17)Children’s Hospital of Eastern Ontario and University of Ottawa, Division of Gastroenterology- Hepatology & Nutrition, Ottawa, Canada;(18)Izaak Walton Killam Hospital- Dalhousie University, Division of Gastroenterology, Halifax, Canada;(19)University of Calgary, Department of Gastroenterology, Calgary, Canada;(20)Queen's University, Gastrointestinal Diseases Research Unit- Department of Medicine, Kingston, Canada;(21)Shaare Zedek Medical Center- The Hebrew University of Jerusalem, The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel;(22)Soroka University Medical Center and Faculty of Health Sciences- Ben-Gurion University of the Negev, Pediatric Gastroenterology Unit, Beer-Sheva, Israel;Crohn’s and Colitis Canada Genetics Environment Microbial Project Research Consortium
P701: Compositional and functional alterations of the gut microbiome are associated with impaired intestinal permeability in healthy relatives of patients with Crohn's diseaseECCO'22Year: 2022
Authors: Leibovitzh, H.(1);Lee, S.H.(1);Xue, M.(1);Raygoza Garay, J.A.(1);Hernandez-Rocha, C.(1);Madsen, K.L.(2);Meddings, J.B.(3);Guttman, D.S.(4);Espin-Garcia, O.(5);Smith, M.I.(6);Goethel, A.(6);Moayyedi, P.(7);Steinhart, A.H.(1);Panancionne, R.(8);Huynh, H.(9);Jacobson, K.(10);Aumais, G.(11);Mack, D.R.(12);Abreu, M.(13);Bernstein, C.N.(14);Marshall, J.K.(15);Turner, D.(16);Xu, W.(5);Turpin, W.(1);Croitoru, K.(1);
(1)Zane Cohen Centre for Digestive Diseases- Mount Sinai Hospital, Division of Gastroenterology & Hepatology- Temerty Faculty of Medicine- University of Toronto, Toronto, Canada;(2)University of Alberta, Department of Medicine- Division of Gastroenterology, Edmonton, Canada;(3)Cumming School of Medicine, Department of Medicine, Calgary, Canada;(4)Centre for the Analysis of Genome Evolution & Function- University of Toronto, Department of Cell & Systems Biology- University of Toronto, Toronto, Canada;(5)Dalla Lana School of Public Health- University of Toronto, Division of Biostatistics, Toronto, Canada;(6)Zane Cohen Centre for Digestive Diseases- Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada;(7)McMaster University- Farncombe Family Digestive Health Research Institute, Department of Medicine, Hamilton, Canada;(8)University of Calgary, Inflammatory Bowel Disease Clinic- Division of Gastroenterology and Hepatology of Gastroenterology, Calgary, Canada;(9)Faculty of Medicine and Dentistry- University of Alberta, Division of Gastroenterology and Nutrition- Department of Pediatrics, Edmonton, Canada;(10)Canadian Gastro-Intestinal Epidemiology Consortium, Children's Hospital- British Columbia Children's Hospital Research Institute- University of British Columbia, Vancouver, Canada;(11)Montreal University, Hôpital Maisonneuve-Rosemont- Department of Medicine, Montreal, Canada;(12)Children’s Hospital of Eastern Ontario and University of Ottawa, Division of Gastroenterology- Hepatology & Nutrition, Ottawa, Canada;(13)University of Miami Miller School of Medicine, Department of Medicine- Division of Gastroenterology-Crohn's and Colitis Center, Miami, United States;(14)University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Department of Internal Medicine- Max Rady College of Medicine- Rady Faculty of Health sciences- University of Manitoba, Winnipeg, Canada;(15)Farncombe Family Digestive Health Research Institute, Department of Medicine- McMaster University, Hamilton, Canada;(16)The Hebrew University of Jerusalem, The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition- Shaare Zedek Medical Center, Jerusalem, Israel;Submitted on behalf of the CCC-GEM Consortium
P702: Faecal Microbiota Transplantation Sculpts the faecal and mucosal microbial and metabolomic profiles in patients with Ulcerative ColitisECCO'22Year: 2022
Authors: Bajaj, A.(1);Markandey, M.(1);Singh, M.(1);Virmani, S.(1);Vuyyuru, S.K.(1);Kante, B.(1);Thirunavukkarasu, R.(2);Verma, M.(1);Kumar, P.(1);Kshetrapal, P.(2);Makharia, G.(1);Gupta, D.(3);Kedia, S.(1);Ahuja, V.(1);
(1)All India Institute of Medical Sciences, Department of Gastroenterology and Human Nutrition, New Delhi, India;(2)Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad 121001, India;(3)International Centre for Genetic Engineering and Biotechnology ICGEB, International Centre for Genetic Engineering and Biotechnology ICGEB, New Delhi, India;
P703: Gut bacteria composition and familiality echo Inflammatory Bowel Disease type and pathological spectrumECCO'22Year: 2022
Authors: Martinez-Gili, L.(1);Gordon, H.(2);Blad, W.(2);McDonald, J.A.K.(1);Holmes, E.(1);Marchesi, J.R.(1);Harbord, M.(2);
(1)Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom;(2)Royal London Hospital, Department of Gastroenterology, London, United Kingdom;
P704: Bifidobacterium longum species protect murine colitis through different activation repertoires of immune cellsECCO'22Year: 2022
Authors: Kim, J.H.(1,2);I Seul, P.(1,2);Mijeong, S.(1,2);YooJin, S.(1,2);Kibeom, K.(1,2);Hyun Woo, M.(1,2);Tae Il, K.(1,2);Won Ho, K.(1,2);Seung Won, K.(1,2,3);Jae Hee, C.(1,2,3);
(1)Yonsei University College of Medicine, Internal Medicine and Institute of Gastroenterology, Seoul, Korea- Republic Of;(2)Yonsei University College of Medicine, Brain Korea 21 PLUS Project for Medical Science, Seoul, Korea- Republic Of;(3)Yonsei University College of Medicine, Severance Biomedical Science Institute, Seoul, Korea- Republic Of;
P705: The effects of commonly consumed dietary fibres on the gut microbiome and its fibre fermentative capacity in adults with inflammatory bowel disease in remissionECCO'22Year: 2022
Authors: Gerasimidis, K.(1);Nichols, B.(1);McGowan, M.(1);Svolos, V.(1);Papadopoulou, R.(1);Kokkorou, M.(1);Rebull, M.(1);Bello Gonzalez, T.(1);Hansen, R.(1);Russell, R.K.(1);Gaya, D.R.(1);
(1)Glasgow Royal Infirmary New Lister Building, Department of Human Nutrition- School of Medicine- College of Medical- Veterinary and Life Sciences, Glasgow, United Kingdom;
P706: A distinct subset of tissue-resident Th17 cells expands in the inflamed intestines of Crohn’s Disease patients and responds to colitogenic bacteriaECCO'22Year: 2022
Authors: ParoniPhD, M.(1);Leccese, G.(1);Ranzani, V.(2);Pagani, M.(3);Landini, P.(1);Vecchi, M.(4);Abrignani, S.(2);Facciotti, F.(5);Caprioli, F.(4);Geginat, J.(2);
(1)University of Milan, Department of Biosciences, Milano, Italy;(2)INGM-National Institute of Molecular Genetics “Romeo ed Enrica Invernizzi”, INGM-National Institute of Molecular Genetics “Romeo ed Enrica Invernizzi”, Milano, Italy;(3)FIRC Institute of Molecular Oncology IFOM- 20139 Milan- Italy, FIRC Institute of Molecular Oncology IFOM- 20139 Milan- Italy, Milano, Italy;(4)Gastroenterology and Endoscopy Unit- Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit- Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy;(5)Department of Experimental Oncology- European Institute of Oncology-, Department of Experimental Oncology- European Institute of Oncology-, Milano, Italy;
P707: Microbial signature of the colon is not associated with response to vedolizumab in Crohn’s diseaseECCO'22Year: 2022
Authors: HagemanMD, I.(1,2);Joustra, V.(1);Li Yim, A.(2,3);Davids, M.(4);Henneman, P.(3);Hakvoort, T.(2);Probert, F.(5);Satsangi, J.(6);D'Haens, G.(1);De Jonge, W.(2);
(1)Amsterdam UMC- University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC- University of Amsterdam, Tytgat institute for for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Amsterdam UMC- University of Amsterdam, Genome Diagnostics Laboratory- Department of Human Genetics, Amsterdam, The Netherlands;(4)Amsterdam UMC- University of Amsterdam, Laboratory of Experimental Vascular Medicine- Academic Medical Center, Amsterdam, The Netherlands;(5)Oxford University, Department of Chemistry- Chemistry Research Laboratory- Mansfield Road, Oxford, United Kingdom;(6)Oxford University, Translational Gastroenterology Unit- NIHR Oxford Biomedical Research Centre- Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;On behalf of the EPIC-Pioneer consortium
